Search Results - "Kraetke, O"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Achieving signalling selectivity of ligands for the corticotropin‐releasing factor type 1 receptor by modifying the agonist's signalling domain by Beyermann, M, Heinrich, N, Fechner, K, Furkert, J, Zhang, W, Kraetke, O, Bienert, M, Berger, H

    Published in British journal of pharmacology (01-07-2007)
    “…Background and purpose: Most of the pharmaceuticals target G‐protein‐coupled receptors (GPCRs) which can generally activate different signalling events. The…”
    Get full text
    Journal Article
  2. 2

    Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent by Schwarz, Anja, Krätke, Oliver, Burwinkel, Michael, Riemer, Constanze, Schultz, Julia, Henklein, Peter, Bamme, Theresa, Baier, Michael

    Published in Neuroscience letters (30-10-2003)
    “…Several lines of evidence suggest that immunisations may be helpful in the prophylaxis and treatment of neurodegenerative amyloidoses like Alzheimer's disease…”
    Get full text
    Journal Article
  3. 3

    Photoaffinity Cross-Linking of the Corticotropin-Releasing Factor Receptor Type 1 with Photoreactive Urocortin Analogues by Kraetke, Oliver, Holeran, Brian, Berger, Hartmut, Escher, Emanuel, Bienert, Michael, Beyermann, Michael

    Published in Biochemistry (Easton) (29-11-2005)
    “…Interaction of natural peptide ligands with class 2 GPCRs, which are targets of biologically important hormones such as glucagon, secretin, and…”
    Get full text
    Journal Article
  4. 4

    Dimerization of Corticotropin-Releasing Factor Receptor Type 1 Is Not Coupled to Ligand Binding by KRAETKE, OLIVER, WIESNER, BURKHARD, EICHHORST, JENNY, FURKERT, JENS, BIENERT, MICHAEL, BEYERMANN, MICHAEL

    “…As described previously, receptor dimerization of G protein-coupled receptors may influence signaling, trafficking, and regulation in vivo. Up to now, most…”
    Get full text
    Journal Article